Latest News and Press Releases

Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "Biosimilar Contract Manufacturing Market Size, Share & Trends Analysis Report by Source (Mammalian, Non-mammalian), Therapeutic Area (Oncology,...

Dublin, Sept. 12, 2025 (GLOBE NEWSWIRE) -- The "Oncology Biosimilars Market Report by Drug Type, and Region 2025-2033" has been added to ResearchAndMarkets.com's offering. The global oncology...

Dublin, Aug. 06, 2025 (GLOBE NEWSWIRE) -- The "Biosimilars Training Course" has been added to ResearchAndMarkets.com's offering. Prepare for the biosimilar market growth as some of the world's...

Dublin, July 24, 2025 (GLOBE NEWSWIRE) -- The "Biosimilars Market by Drug Class (mAbs (Adalimumab, Infliximab, Rituximab, Trastuzumab), GCSF, Insulin, Anticoagulant, rhGH, Teriparatide, GLP-1),...

Dublin, May 14, 2025 (GLOBE NEWSWIRE) -- The "Europe Biosimilars Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user,...

Dublin, May 06, 2025 (GLOBE NEWSWIRE) -- The "Biosimilars - Through the Physician's Lens" report has been added to ResearchAndMarkets.com's offering.Since their introduction within the past few...

Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "Biosimilars: Global Markets" has been added to ResearchAndMarkets.com's offering. The global biosimilars market is on an impressive growth...

Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Biosimilars Market - Products, Applications and Regulations" report has been added to ResearchAndMarkets.com's offering. The global biosimilars...

Dublin, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The "Immunology Biosimilars Market (2024 Edition): Analysis By Indication (Arthritis, Irritable Bowel Disease, Other Indications), By Distribution Channel,...

Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "Eculizumab (Soliris) Biosimilars & Biosuperiors Pipeline Review" report has been added to ResearchAndMarkets.com's offering.This product provides...